The future of HIV testing

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue SUPPL. 2, 2010, Pages

  Branson, Bernard M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acute HIV infection; HIV antibody tests; HIV confirmatory tests; HIV diagnosis

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ALGORITHM; ENZYME IMMUNOASSAY; FOOD AND DRUG ADMINISTRATION; HIV TESTING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; WESTERN BLOTTING;

AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOASSAY; RNA, VIRAL;

EID: 78649362830     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181fbca44     Document Type: Review

References (36)

1. Meyer KB, Pauker SG. Screening for HIV: can we afford the false positive rate? N Engl J Med. 1987;317:238-241.
2. Centers for Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep. 1989;38(Suppl 7): S1-S7.
3. Campsmith ML, Rhodes PH, Hall HI, et al. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53:619-624. doi: 10.1097/QAI. 0b013e3181bf1c45.
4. Busch MP, Lee LL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion. 1995;35:91-97.
5. Association of Public Health Laboratories. Public Health Laboratory Issues in Brief: 2006 HIV Diagnostics Survey. Silver Spring, MD: Association of Public Health Laboratories; November 2007. Available at: http://www.aphl.org/ aphlprograms/infectious/documents/hiv-issue-brief-2007.pdf. Accessed August 8, 2010.
6. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17:1871-1879. doi: 10.1097/01.aids. 0000076308.76477.b8.
7. Association of Public Health Laboratories. HIV: 2009 Diagnostic Survey. Silver Spring, MD: Association of Public Health Laboratories; March 2010. Available at: http://www.aphl.org/aphlprograms/infectious/hiv/Documents/HIV- 2009-Survey.pdf. Accessed August 8, 2010. Issues in Brief: Member Survey of HIV Assay Use.
8. Owen SM, Yang C, Spira T, et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol. 2008;46:1588-1595. PMCID: PMC2395119.
9. Food and Drug Administration. Approval Letter-APTIMA® HIV-1 RNA Qualitative Assay. October 4, 2006. Available at: http://www.fda. gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/ LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm149928.htm. Accessed August 8, 2010.
10. Centers for Disease Control and Prevention. Update: HIV counseling and testing using rapid tests-United States, 1995. MMWR Morb Mortal Wkly Rep. 1998;47:211-215.
11. Greenwald JL, Burstein GR, Pincus J, et al. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep. 2006;8:125-131.
12. Hutchinson AB, Branson BM, Kim A, et al. A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS. 2006;20:1597-1604.
13. Martin EG, Salaru G, Paul SM, et al. Statewide implementation of "rapidrapid" testing in New Jersey: our first 25, 000. Presented at: 2010 HIV Diagnostics Conference; March 24-26, 2010; Orlando, FL. Available at: http://www.hivtestingconference.org/PDF/Presentations/Martin.pdf [page 18]. Accessed August 18, 2010.
14. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a highincidence population: is antibody testing alone good enough? Clin Infect Dis. 2009;49:444-453. doi: 10.1086/600043.
15. Food and Drug Administration. Letter-ADVIA Centaur HIV 1/O/2 Enhanced ReadyPack Reagents. May 18, 2996. Available at: http://www.fda.gov/ BiologicsBloodVaccines/BloodBloodProducts/Approved Products/ PremarketApprovalsPMAs/ucm091283.htm. Accessed August 8, 2010.
16. Food and Drug Administration. Approval of VITROS Anti-HIV 1+2 diagnostic immunoassay [announcement]. March 27, 2008. Available at: http://www.fda.gov/ ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm121720.htm. Accessed August 18, 2010.
17. Food and Drug Administration. Approval Letter-ARCHITECT HIV Ag/Ab Combo. June 18, 2010. Available at: http://www.fda.gov/Biologics BloodVaccines/ BloodBloodProducts/ApprovedProducts/LicensedProducts BLAs/BloodDonorScreening/ InfectiousDisease/ucm216300.htm. Accessed August 8, 2010.
18. Pilcher CD, Eron JJ Jr, Galvin S, et al. Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest
19. [erratum: J Clin Invest. 2006;116:3292].
20. 2004;113:937-945. PMCID: PMC379335.
21. Morrison CS, Demers K, Kwok C, et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS. 2010;24:573-582. doi: 10.1097/QAD.0b013e32833433df.
22. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis. 2008;198:687-693. doi: 10.1086/590501.
23. Jacquez JA, Koopman JS, Simon CP, et al. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr. 1994;7:1169-1184.
24. Brenner BG, Roger M, Arouty JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis. 2007;195:951-959. doi: 10.1086/512088.
25. Prabhu VS, Hutchinson AB, Farnham PG, et al. Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update. AIDS. 2009;23:1792-1794. doi:10.1097/QAD.0b013e32832e7d04.
26. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med. 2005;352:1873-1883.
27. Patel P, MacKellar D, Simmons P, et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med. 2010;170:66-74.
28. Centers for Disease Control and Prevention. Acute HIV infection-New York City, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:1296-1299. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5846a3.htm. Accessed August 8, 2010.
29. Pandori MW, Hackett J Jr, Louie B, et al. Assessment of the ability of a fourthgeneration immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol. 2009;47:2639-2642. PMCID: PMC2725691.
30. Dougan S, Patel B, Tosswill JH, et al. Diagnoses of HIV-1 and HIV-2 in England, Wales, and Northern Ireland associated with west Africa. Sex Transm Infect. 2005;81:338-341. PMCID: PMC1745000.
31. Dragavon J, Gallardo C, Espinosa E, et al. Use of Multispot HIV-1/HIV-2 Rapid Test to confirm HIV-1/HIV-2 Plus O Enzyme immunoassay results, shorten reporting time for HIV testing and identify cryptic HIV-2 infection. Presented at: 2010 HIV Diagnostics Conference; March 24-26, 2010; Orlando, FL. Available at: http://www.hivtestingconference.org/PDF/Presentations/Coombs.pdf. Accessed August 18, 2010.
32. Ren J, Bird LE, Chamberlain PP, et al. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to nonnucleoside inhibitors. Proc Natl Acad Sci U S A. 2002;99:14410-14415. PMCID: PMC137897.
33. Branson B. Conference wrap-up: unified laboratory algorithm. Presented at: 2010 HIV Diagnostics Conference; March 24-26, 2010; Orlando, FL.
34. Moore ZS, McCoy S, Kuruc J, et al. Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infection. J Acquir Immune Defic Syndr. 2009;52:509-513.
35. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. US Department of Health and Human Services; December 1, 2009. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed August 8, 2010.
36. Menza TW, Hughes JP, Celum CL, et al. Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis. 2009;36:547-555. doi: 10.1097/OLQ.0b013e3181a9cc41.